European Organisation for Research and Treatment of Cancer - EORTC: Leukemia trials

The registry lists 26 Leukemia studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 7Phase 3 17No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• "InDACtion" vs "3+7" Induction in AMLStatus unknownNCT02172872Phase 3
• A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)CompletedNCT01324063Phase 3
• Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998Status unknownNCT01298388
• Empirical Versus Preemptive Antifungal TherapyCompletedNCT01288378Phase 3
• Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT01185886
• Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaStatus unknownNCT00838240Phase 1/2
• Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaStatus unknownNCT00091234Phase 2/3
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic SyndromeCompletedNCT00077116Phase 2
• Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerTerminatedNCT00062231Not applicable
• Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00052299Phase 3
• Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic SyndromeStatus unknownNCT00043134Phase 3
• Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic LeukemiaStatus unknownNCT00017108Phase 3
• Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00006122Phase 2
• Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid LeukemiaStatus unknownNCT00004128Phase 3
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3
• Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous LeukemiaStatus unknownNCT00003758Phase 2
• Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic LeukemiaTerminatedNCT00003729Phase 2
• Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's LymphomaStatus unknownNCT00003728Phase 3
• Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous LeukemiaCompletedNCT00003148Phase 2
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeStatus unknownNCT00002989Phase 3
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaStatus unknownNCT00002926Phase 3
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00002719Phase 3
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic LeukemiaStatus unknownNCT00002701Phase 3
• Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic LeukemiaCompletedNCT00002700Phase 3
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous LeukemiaStatus unknownNCT00002549Phase 3
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002517Phase 3